Evolving Artificial Intelligence (AI) at the Crossroads: Potentiating Productive vs. Declining Disruptive Cancer Research DOI Open Access
Nilesh Kumar Sharma, Sachin C. Sarode

Cancers, Journal Year: 2024, Volume and Issue: 16(21), P. 3646 - 3646

Published: Oct. 29, 2024

Artificial intelligence (AI), encompassing several tools and platforms such as artificial “general” (AGI) generative (GenAI), has facilitated cancer research, enhancing productivity in terms of research publications translational value for patients. AGI tools, ChatGPT, assist preclinical clinical scientists identifying tumor heterogeneity, predicting therapy outcomes, streamlining publications. However, this perspective review also explores the potential AI’s influence on with regard to its impact disruptive sciences discoveries by scientists. The increasing reliance AI may compromise biological intelligence, disrupting abstraction, creativity, critical thinking. This could contribute declining trend sciences, hindering landmark innovations. narrates role different forms potentiation productive disruption due influence.

Language: Английский

Bridging machine learning and peptide design for cancer treatment: a comprehensive review DOI Creative Commons
Khosro Rezaee, Hossein Eslami

Artificial Intelligence Review, Journal Year: 2025, Volume and Issue: 58(5)

Published: March 5, 2025

Language: Английский

Citations

0
DTLCDR: A target-based multimodal fusion deep learning framework for cancer drug response prediction DOI Creative Commons
Jie Yu, Cheng Shi, Yiran Zhou

et al.

Journal of Pharmaceutical Analysis, Journal Year: 2025, Volume and Issue: unknown, P. 101315 - 101315

Published: April 1, 2025

Language: Английский

Citations

0
Unlocking therapeutic frontiers: harnessing artificial intelligence in drug discovery for neurodegenerative diseases DOI
Bilal Nehmeh, Joseph Rebehmed,

Riham Nehmeh

et al.

Drug Discovery Today, Journal Year: 2024, Volume and Issue: 29(12), P. 104216 - 104216

Published: Oct. 18, 2024

Language: Английский

Citations

0
Evolving Artificial Intelligence (AI) at the Crossroads: Potentiating Productive vs. Declining Disruptive Cancer Research DOI Open Access
Nilesh Kumar Sharma, Sachin C. Sarode

Cancers, Journal Year: 2024, Volume and Issue: 16(21), P. 3646 - 3646

Published: Oct. 29, 2024

Artificial intelligence (AI), encompassing several tools and platforms such as artificial “general” (AGI) generative (GenAI), has facilitated cancer research, enhancing productivity in terms of research publications translational value for patients. AGI tools, ChatGPT, assist preclinical clinical scientists identifying tumor heterogeneity, predicting therapy outcomes, streamlining publications. However, this perspective review also explores the potential AI’s influence on with regard to its impact disruptive sciences discoveries by scientists. The increasing reliance AI may compromise biological intelligence, disrupting abstraction, creativity, critical thinking. This could contribute declining trend sciences, hindering landmark innovations. narrates role different forms potentiation productive disruption due influence.

Language: Английский

Citations

0